GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Malaysian Genomics Resource Centre Bhd (XKLS:0155) » Definitions » Cash, Cash Equivalents, Marketable Securities

Malaysian Genomics Resource Centre Bhd (XKLS:0155) Cash, Cash Equivalents, Marketable Securities : RM0.44 Mil (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Malaysian Genomics Resource Centre Bhd Cash, Cash Equivalents, Marketable Securities?

Malaysian Genomics Resource Centre Bhd's quarterly cash, cash equivalents, marketable securities increased from Mar. 2023 (RM3.58 Mil) to Sep. 2023 (RM3.69 Mil) but then stayed the same from Sep. 2023 (RM3.69 Mil) to Mar. 2024 (RM0.44 Mil).

Malaysian Genomics Resource Centre Bhd's annual cash, cash equivalents, marketable securities declined from Jun. 2019 (RM4.21 Mil) to Jun. 2020 (RM0.00 Mil) but then increased from Jun. 2020 (RM0.00 Mil) to Jun. 2021 (RM11.31 Mil).


Malaysian Genomics Resource Centre Bhd Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Malaysian Genomics Resource Centre Bhd's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Malaysian Genomics Resource Centre Bhd Cash, Cash Equivalents, Marketable Securities Chart

Malaysian Genomics Resource Centre Bhd Annual Data
Trend Jun12 Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21
Cash, Cash Equivalents, Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.88 6.34 4.21 - 11.31

Malaysian Genomics Resource Centre Bhd Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Mar24
Cash, Cash Equivalents, Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.85 3.47 3.58 3.69 0.44

Malaysian Genomics Resource Centre Bhd Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Malaysian Genomics Resource Centre Bhd  (XKLS:0155) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Malaysian Genomics Resource Centre Bhd Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Malaysian Genomics Resource Centre Bhd's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Malaysian Genomics Resource Centre Bhd (XKLS:0155) Business Description

Traded in Other Exchanges
N/A
Address
8F, Jalan Teknologi 3/6, Taman Sains, Petaling Jaya, SGR, MYS, 47810
Malaysian Genomics Resource Centre Bhd is a Malaysia-based company engaged in providing laboratory services. It primarily offers genome sequencing and analysis (GSA) services, genetic screening services (GSS), and pathology services. GSA services involve the sequencing and analysis of the DNA of humans, animals, plants, and microbes, to discover meaningful biological information. The company is engaged in providing GSS by developing its own range of genetic screening tests under the brand Dtect which screen human DNA for genetic markers related to diseases and health conditions. It derives the majority of its revenue from Pathology services.

Malaysian Genomics Resource Centre Bhd (XKLS:0155) Headlines

No Headlines